JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB84700

Recombinant Human Tau441 protein

Be the first to review this product! Submit a review

|

(6 Publications)

Recombinant Human Tau 441 protein is a Human Full Length protein in the 1 to 441 aa range with >90% purity and suitable for western blot and SDS-PAGE. The predicted molecular weight of ab84700 protein is 64 kDa.

- Save time and ensure accurate results - use our recombinant Human Tau-441 (2N4R) protein as a control
- Available in different sizes to fit your experimental needs

View Alternative Names

TAU, MAPT, MSTD, PPND, pTau, DDPAC, MAPTL, MTBT1, MTBT2, Mtapt, Tau-C, FTDP17, RNPTAU, FTDP 17, PHF tau, PHF-tau, 2N3R Tau, 2N4R Tau, AI413597, AW045860, FLJ31424, PPP1R103, MGC134287, MGC138549, MGC156663, TAU_HUMAN, Paired helical filament tau, Paired helical filament-tau, Neurofibrillary tangle protein, Tauopathy and respiratory failure, Microtubule associated protein tau, Microtubule-associated protein tau, Tauopathy and respiratory failure, included, Microtubule associated protein tau isoform 4, Protein phosphatase 1, regulatory subunit 103, G protein beta1/gamma2 subunit interacting factor 1

1 Images
SDS-PAGE - Recombinant Human Tau441 protein (AB84700)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant Human Tau441 protein (AB84700)

SDS-PAGE of ab84700. Approximate MWt 64 kDa (46 kDa by MWt calculation).

Key facts

Purity

>90% SDS-PAGE

Expression system

Escherichia coli

Tags

Tag free

Applications

WB, SDS-PAGE

applications

Biologically active

No

Accession

P10636

Animal free

No

Carrier free

No

Species

Human

Storage buffer

pH: 7.5 Constituents: 25% Glycerol (glycerin, glycerine), 0.87% Sodium chloride, 0.79% Tris HCl, 0.00385% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.00174% PMSF

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Ensure the validity of your result using our recombinant human Tau-441 (2N4R) as a control in SDS-PAGE and western blot.


Check out our protein gel staining guide for SDS-PAGE here

Check out oour western blot protocol for more information here

Sequence info

[{"sequence":"MAEPRQEFEVMEDHAGTYGLGDRKDQGGYTMHQDQEGDTDAGLKESPLQTPTEDGSEEPGSETSDAKSTPTAEDVTAPLVDEGAPGKQAAAQPHTEIPEGTTAEEAGIGDTPSLEDEAAGHVTQARMVSKSKDGTGSDDKKAKGADGKTKIATPRGAAPPGQKGQANATRIPAKTPPAPKTPPSSGEPPKSGDRSGYSSPGSPGTPGSRSRTPSLPTPPTREPKKVAVVRTPPKSPSSAKSRLQTAPVPMPDLKNVKSKIGSTENLKHQPGGGKVQIINKKLDLSNVQSKCGSKDNIKHVPGGGSVQIVYKPVDLSKVTSKCGSLGNIHHKPGGGQVEVKSEKLDFKDRVQSKIGSLDNITHVPGGGNKKIETHKLTFRENAKAKTDHGAEIVYKSPVVSGDTSPRHLSNVSSTGSIDMVDSPQLATLADEVSASLAKQGL","proteinLength":"Full Length","predictedMolecularWeight":"64 kDa","actualMolecularWeight":null,"aminoAcidEnd":441,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":"Escherichia coli","accessionNumber":"P10636","tags":[]}]

Properties and storage information

Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-80°C
Appropriate long-term storage conditions
-80°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
False

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tau441 also known as microtubule-associated protein tau (MAPT) plays an important role in stabilizing microtubules within neuronal cells. This protein has a molecular weight of approximately 50 kilodaltons. Tau441 is most highly expressed in neurons of the central nervous system. It assists in maintaining neuronal structure and due to its microtubule-binding domains contributes to proper axonal transport. The proper function of Tau441 is essential for neuronal health and function.
Biological function summary

Tau441 is an important component in the assembly and stability of microtubule structures. It associates with other tau isoforms to form a microtubule lattice complex important for neuron polarization and intracellular transport. Tau441 influences cell signaling and synaptic function by regulating microtubule dynamics. It also interacts with motor proteins to facilitate the transport of organelles playing a significant role in maintaining neuron structure and functionality under physiological conditions.

Pathways

Tau441 is involved in the MAP kinase signaling pathway and the regulation of cytoskeleton organization. It interacts with proteins like kinases that phosphorylate tau affecting its microtubule-binding capability highlighting its role in intracellular transport processes. Tau441 modulates the structure and dynamics of microtubules enabling effective transmission of cellular signals and materials throughout the neuron which is vital in maintaining neuronal integrity and function.

Tau441 is notably associated with Alzheimer's disease and frontotemporal dementia. Abnormal phosphorylation of Tau441 results in the formation of neurofibrillary tangles a hallmark of Alzheimer's disease. The dysregulated interaction between Tau441 and kinases like glycogen synthase kinase-3 (GSK-3) leads to tau hyperphosphorylation contributing to neuronal degeneration. These pathological changes in Tau441 are linked to the onset and progression of neurodegenerative diseases emphasizing the importance of studying and targeting Tau441 in clinical research and therapeutics.

Specifications

Form

Liquid

Additional notes

Purity >90% as determined by densitometry.

General info

Function

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.

Post-translational modifications

Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1, CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1, MARK2, MARK3 or MARK4), causing detachment from microtubules, and their disassembly (PubMed:23666762, PubMed:7706316). Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tau/MAP's interaction with, respectively, microtubules or plasma membrane components (PubMed:7706316). Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717. Dephosphorylated at several serine and threonine residues by the serine/threonine phosphatase PPP5C.. Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome (By similarity). PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.. O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.. Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle formation in AD.

Subcellular localisation

Cytoskeleton

Product protocols

Target data

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
See full target information TAU_HUMAN

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 11:e2406196 PubMed39297315

2024

Integrated Ultrasound-Enrichment and Machine Learning in Colorimetric Lateral Flow Assay for Accurate and Sensitive Clinical Alzheimer's Biomarker Diagnosis.

Applications

Unspecified application

Species

Unspecified reactive species

Shuqing Wang,Yan Zhu,Zhongzeng Zhou,Yong Luo,Yan Huang,Yibiao Liu,Tailin Xu

Frontiers in aging neuroscience 14:863673 PubMed35645782

2022

Machine Learning Reveals a Multipredictor Nomogram for Diagnosing the Alzheimer's Disease Based on Chemiluminescence Immunoassay for Total Tau in Plasma.

Applications

Unspecified application

Species

Unspecified reactive species

Lingyu Zhang,Danhua Wang,Yibei Dai,Xuchu Wang,Ying Cao,Weiwei Liu,Zhihua Tao

Alzheimer's & dementia : the journal of the Alzheimer's Association 18:2481-2492 PubMed35142027

2022

Trans-seeding of Alzheimer-related tau protein by a yeast prion.

Applications

Unspecified application

Species

Unspecified reactive species

Martin Flach,Cedric Leu,Alfonso Martinisi,Zhiva Skachokova,Stephan Frank,Markus Tolnay,Henning Stahlberg,David T Winkler

Biochimica et biophysica acta. Proteins and proteomics 1870:140755 PubMed34999006

2022

Biochemical and biophysical features of disease-associated tau mutants V363A and V363I.

Applications

Unspecified application

Species

Unspecified reactive species

Ada De Luigi,Laura Colombo,Luca Russo,Caterina Ricci,Antonio Bastone,Sara Cimini,Fabrizio Tagliavini,Giacomina Rossi,Laura Cantù,Elena Del Favero,Mario Salmona

The Journal of biological chemistry 296:100664 PubMed33865852

2021

Nonphosphorylated tau slows down Aβ aggregation, binds to Aβ oligomers, and reduces Aβ toxicity.

Applications

Unspecified application

Species

Unspecified reactive species

Marten Beeg,Elisabetta Battocchio,Ada De Luigi,Laura Colombo,Carmina Natale,Alfredo Cagnotto,Alessandro Corbelli,Fabio Fiordaliso,Luisa Diomede,Mario Salmona,Marco Gobbi

Molecular diagnosis & therapy 22:729-735 PubMed30377977

2018

Detection of a Traumatic Brain Injury Biomarker at the 10 fg/mL Level.

Applications

Unspecified application

Species

Unspecified reactive species

Anup S Mathew,Xuyang Shi,Siu-Tung Yau
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com